JAC Advance Access originally published online on September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2002) 50, 479-486
© 2002 The British Society for Antimicrobial Chemotherapy
Evaluation of media available for testing the susceptibility of Pseudomonas aeruginosa by BSAC methodology
1 Department of Microbiology, City Hospital NHS Trust, Birmingham, UK and 2 Department of Microbiology, St Thomas’ Hospital, London, UK
Received 25 February 2002; returned 15 May 2002; revised 26 June 2002; accepted 18 July 2002
BSAC methodology was used to study media available from four manufacturers for susceptibility testing of Pseudomonas aeruginosa in the UK and Ireland. Fifty isolates of P. aeruginosa, including ATCC and NCTC control strains, were studied by disc testing methods by 20 centres around the UK and Ireland and by MIC determination at the BSAC Standardized Method Development Centre (SMDC) in Birmingham, UK. Although many of the antibiotics tested gave similar zone diameters for a particular strain–antibiotic combination irrespective of the medium used for testing, significant differences in media performance were noted for the aminoglycosides, imipenem and colistin. The data generated showed that for testing aminoglycosides, zone diameters on two of the agars were significantly larger than those on Oxoid IsoSensitest agar—the recommended medium for the BSAC method. For imipenem, zones were smaller on one of the agars and for colistin, zones were larger on one of the agars in comparison with those on Oxoid agar. Scattergram analysis of zone diameters and MICs of colistin indicated that the zone diameter breakpoints should be adjusted. Media purported to be equivalent to Oxoid IsoSensitest agar do not give the same zone sizes with some agents and should not be used until standards for media performance have been established and the media have been shown to perform adequately.
* Corresponding author. Tel: +44-121-507-5693; Fax : +44-121-551-7763; E-mail: jenny.andrews{at}cityhospbham.wmids.nhs.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. R. Lo-Ten-Foe, A. M. G. A. de Smet, B. M. W. Diederen, J. A. J. W. Kluytmans, and P. H. J. van Keulen Comparative Evaluation of the VITEK 2, Disk Diffusion, Etest, Broth Microdilution, and Agar Dilution Susceptibility Testing Methods for Colistin in Clinical Isolates, Including Heteroresistant Enterobacter cloacae and Acinetobacter baumannii Strains Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3726 - 3730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Tan and L. S. Y. Ng Comparison of three standardized disc susceptibility testing methods for colistin J. Antimicrob. Chemother., October 1, 2006; 58(4): 864 - 867. [Abstract] [Full Text] [PDF]
|
|